| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 427,783 | 470,371 | 450,380 | 445,863 | | Cost of Revenue | (509,304) | 256,571 | 252,733 | 20,024 | | | Gross Profit | 937,087 | 213,800 | 197,647 | 425,839 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 856,479 | 117,464 | 115,727 | 347,549 | | Non Recurring | 26,542 | (8,455) | 8,455 | (25,976) | | Others | (6,111) | 28,196 | 10,999 | 45,345 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,177 | 76,595 | 62,466 | 58,921 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 60,177 | 76,595 | 62,466 | 58,921 | | Interest Expense | 17,330 | 18,825 | 17,277 | 19,208 | | Income Before Tax | 42,847 | 57,770 | 45,189 | 39,713 | | Income Tax Expense | 16,413 | 22,047 | 17,254 | 15,091 | | Minority Interest | (338) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,434 | 35,723 | 27,935 | 24,622 | | | Non-recurring Events | | Discontinued Operations | 1,711 | (1,109) | (414) | (601) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,807 | 34,614 | 27,521 | 24,021 | | Preferred Stock And Other Adjustments | 345 | (206) | (139) |
-
| | | Net Income Applicable To Common Shares | $28,152 | $34,408 | $27,382 | $24,021 |
|
0.51% Nasdaq 
Income Statement
